AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics

Summit Therapeutics Inc. (NASDAQ:SMMT) today announced key developments important to the company’s progress towards achieving its goal of making a significant difference in the lives of patients with cancer. Specifically, Summit has established agreements with AstraZeneca (LSE/STO/NYSE:AZN) for a s…